Status:

COMPLETED

A Comparative Study of New Medications for Psychosis in Adolescents

Lead Sponsor:

University of Minnesota

Collaborating Sponsors:

AstraZeneca

Jensen, Jonathan B., M.D.

Conditions:

Psychotic Disorders

Schizophrenia

Eligibility:

All Genders

12-18 years

Phase:

NA

Brief Summary

The overall goal of this study is to determine the efficacy and tolerability of three atypical antipsychotic medications (risperidone, olanzapine, and quetiapine) in the treatment of adolescents with ...

Detailed Description

The purpose of this study is to compare the efficacy and tolerance of three atypical antipsychotics, which are medications that have been in use for about the last 10 years, in the treatment of psycho...

Eligibility Criteria

Inclusion

  • Subjects are between the ages of 12-18 and have a diagnosis of a psychotic illness.
  • Subject currently meets criteria for one of the following disorders: schizophrenia, schizoaffective disorder (mainly schizophrenic), schizophreniform disorder, and psychosis NOS.
  • Subject is in good physical health and not suffering from any medical disorder that might mimic psychosis or lead to medical difficulty with the study medications.
  • If subject is taking antipsychotic medication before study entry, their medicine will be discontinued for 1-4 days depending on symptoms.

Exclusion

  • Subject has a medical disorders that would interfere with the study, such as epilepsy, thyroid disease, liver disease, AIDS, etc.
  • Subject currently has substance dependence.
  • Subject is talking a medication that inhibits or induces the cytochrome P450 3A4 (specific medications listed in Appendix of protocol).
  • 3\. Subject meets criteria for brief psychosis or mood disorder with psychotic features.
  • 4\. Female subject is pregnant or nursing.

Key Trial Info

Start Date :

August 1 2002

Trial Type :

INTERVENTIONAL

End Date :

August 1 2006

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00222495

Start Date

August 1 2002

End Date

August 1 2006

Last Update

September 11 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Minnesota Medical Center

Minneapolis, Minnesota, United States, 55454

A Comparative Study of New Medications for Psychosis in Adolescents | DecenTrialz